PET Brain with FDG-Flourodeoxyglucose
About Test
A PET scan of the brain with FDG (fludeoxyglucose) is a diagnostic imaging test that uses a radioactive tracer called FDG to visualize the metabolic activity of brain cells. The patient receives a small amount of FDG, which is a glucose analog that is taken up by active brain cells. The tracer emits positrons, which are detected by a PET scanner, creating three-dimensional images of brain activity. The images generated by this test can show the distribution of active brain cells and areas of increased or decreased activity.
The clinical uses of PET scan of the brain with FDG are varied, but it is commonly used to evaluate brain function and to detect abnormalities such as tumors, inflammation, and degenerative diseases. It is particularly useful in the evaluation of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. PET scan with FDG is also used to evaluate brain tumors and to monitor the effectiveness of cancer treatments. The test can also be used to evaluate patients with seizures, as well as those with certain psychiatric disorders, such as depression and schizophrenia. By providing detailed images of brain function, a PET scan of the brain with FDG can help healthcare professionals make accurate diagnoses and develop appropriate treatment plans.
Overall, a PET scan of the brain with FDG is a safe and effective test that provides valuable information about brain function and activity. It can help healthcare professionals diagnose and manage a wide range of neurological and psychiatric disorders, as well as monitor the effectiveness of treatments over time.
Frequently ordered together
PET Brain with FDG-Flourodeoxyglucose
PET-Imaging of Head
PET-Imaging of Head and Neck
PET-CT of Head
PET-CT of Head and Neck
1500.00$
3050.00$
3050.00$
3050.00$
3050.00$
See Physicians Online
Conditions Treated
Sarwat Makkani, MD
